hero

Light the way to a career with real world impact

Find your new job in the photonic chip industry.
Showing 60 companies
Coolsem Technologies
Coolsem Technologies

Who we are COOLSEM was founded in 2025 with the mission to remove one of the biggest bottlenecks in high-performance semiconductors: self-heating. By enabling far more effective cooling, we increase device output power, improve efficiency, and reduce system-level overhead. The company is built on a patented technology platform, called WALTIS, and an experienced founder team covering all aspects of the business. The WALTIS innovation At the core of our approach is WALTIS — the wafer-level thermal interface stack. WALTIS is applied directly to the bare device after full substrate removal by epitaxial lift-off. This creates a unique thermal pathway that improves heat transfer from the device to the heatsink by a factor of 15 compared with conventional packaging. WALTIS is distinctive because it addresses all the critical physical requirements in a single stack: mechanical support, high thermal conductivity (≈250 W/m·K), RF isolation, and management of the thermal expansion mismatch between chip and heatsink. The result is that devices can be mounted directly on standard copper heatsinks, eliminating the need for low-conductivity composites such as CuMo or CuW. Compatibility with established joining techniques such as Au/Sn soldering or Ag sintering ensures straightforward adoption. Benefits for device makers This architecture delivers higher performance, longer device lifetimes, and lower cost per chip, thanks to wafer-level processing. By doubling the thermal conductivity of the heatsink and multiplying the chip-to-heatsink conductivity with a factor of 15, WALTIS opens a new performance window that other solutions cannot match. Competing approaches are either prohibitively expensive (e.g., diamond) or significantly less effective (e.g., phase-change materials).

Delta Life Science
Delta Life Science
1 jobs
Biotechnology
Series A

Enabling more. For less. It's our mission to make label-free, multiplexed biosensing accessible to all. Assay developers need to validate next-gen biomarker panels for more accurate diagnostics. Academic researchers need to extract more data from precious samples to guide their studies. Pharma scientists need to speed up drug development by collecting extensive data from a wide range of samples. The merits of label-free biosensing? Label-free biosensing enables real-time, direct detection without the need for tagging target molecules. This revolutionary approach benefits a wide range of applications, from studying molecular interactions and accelerating drug kinetics-screening to selecting high-quality antibodies based on kinetics and developing real-time quantitative biomarker assays. Most platforms focus on one aspect—sensitivity, multiplexing, or cost. Researchers need all three. And the high costs mean it's only accessible for big-budget labs. Powered by photonic integrated circuits, Delta Life Science accelerates research by a factor of 4. By cutting ownership costs by a factor of 5, we make top-notch label-free biosensing accessible to every researcher. As a spinoff of TNO, we develop integrated photonics to create highly sensitive and selective biosensors. These are an order of magnitude more affordable, measure multiple biomarkers, and are extremely sensitive, reaching SPR sensitivity. Our chips and readout device can be used anywhere from medical research, agriculture to point-of-care diagnostic applications.